BCPC - Balchem Corporation
NASDAQ
->
Basic Materials
->
Specialty Chemicals
New Hampton,
United States
Type: Equity
BCPC price evolution
BCPC
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $63.74 | $60.35 | $64.45 | |
| Short term investments | ||||
| Net receivables | $120.54 | $123.4 | $139.88 | $125.28 |
| Inventory | $118.51 | $117.1 | $110.38 | $109.52 |
| Total current assets | $325.99 | $320.16 | $324.86 | $314.24 |
| Long term investments | ||||
| Property, plant & equipment | $294.76 | $290.98 | $293.04 | $295.9 |
| Goodwill & intangible assets | $946.13 | $953.58 | $970.12 | |
| Total noncurrent assets | $1254.81 | $1263.84 | $1282.97 | |
| Total investments | ||||
| Total assets | $1596.94 | $1574.97 | $1588.7 | $1597.21 |
| Current liabilities | ||||
| Accounts payable | $46.46 | $54.5 | $59.8 | $55.5 |
| Deferred revenue | ||||
| Short long term debt | $3.84 | $4.05 | $4.22 | |
| Total current liabilities | $109.44 | $113.32 | $124.42 | $148.49 |
| Long term debt | $228.8 | $282.08 | $317.44 | $326.11 |
| Total noncurrent liabilities | $349.28 | $385.48 | $394.74 | |
| Total debt | $285.92 | $321.49 | $330.33 | |
| Total liabilities | $419.72 | $462.6 | $509.91 | $543.23 |
| Shareholders' equity | ||||
| Retained earnings | $992.38 | $958.54 | $926.47 | $897.49 |
| Other shareholder equity | $14.5 | -$7.13 | -$3.87 | $8.69 |
| Total shareholder equity | $1112.36 | $1078.79 | $1053.98 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $64.45 | $66.56 | $103.24 | $84.57 |
| Short term investments | $5.99 | |||
| Net receivables | $125.28 | $131.58 | $117.41 | $98.21 |
| Inventory | $109.52 | $119.67 | $91.06 | $70.62 |
| Total current assets | $314.24 | $335.8 | $322.23 | $266.89 |
| Long term investments | ||||
| Property, plant & equipment | $295.9 | $290.79 | $246.81 | $236.51 |
| Goodwill & intangible assets | $970.12 | $982.8 | $618.61 | $651.12 |
| Total noncurrent assets | $1282.97 | $1288.71 | $877.09 | $898.96 |
| Total investments | $5.99 | |||
| Total assets | $1597.21 | $1624.51 | $1199.33 | $1165.84 |
| Current liabilities | ||||
| Accounts payable | $55.5 | $57.32 | $56.24 | $23.74 |
| Deferred revenue | ||||
| Short long term debt | $4.22 | $4.02 | $2.36 | $2.34 |
| Total current liabilities | $148.49 | $140.04 | $143.8 | $94.43 |
| Long term debt | $326.11 | $442.78 | $115.68 | $169.65 |
| Total noncurrent liabilities | $394.74 | $546.19 | $178.51 | $243.18 |
| Total debt | $330.33 | $460.61 | $118.04 | $171.99 |
| Total liabilities | $543.23 | $686.23 | $322.31 | $337.61 |
| Shareholders' equity | ||||
| Retained earnings | $897.49 | $814.49 | $732.14 | $656.74 |
| Other shareholder equity | $8.69 | -$7.15 | -$4.99 | $4.17 |
| Total shareholder equity | $1053.98 | $938.28 | $877.01 | $828.23 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $234.08 | $239.66 | $228.7 | |
| Cost of revenue | $151.09 | $158.15 | $153.71 | |
| Gross Profit | $82.99 | $81.51 | $74.99 | |
| Operating activities | ||||
| Research & development | $3.85 | $4.1 | $3.94 | |
| Selling, general & administrative | $33.34 | $35.74 | $32.72 | |
| Total operating expenses | $37.2 | $39.84 | $35.98 | |
| Operating income | $45.8 | $41.68 | $39.02 | |
| Income from continuing operations | ||||
| EBIT | $45.47 | $42.25 | $38.56 | |
| Income tax expense | $9.16 | $7.86 | $6.62 | |
| Interest expense | $4.24 | $5.4 | $5.29 | |
| Net income | ||||
| Net income | $32.07 | $28.99 | $26.65 | |
| Income (for common shares) | $32.07 | $28.99 | $26.65 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $922.44 | $942.36 | $799.02 | $703.64 |
| Cost of revenue | $620.38 | $661.91 | $555.85 | $479.75 |
| Gross Profit | $302.06 | $280.45 | $243.17 | $223.9 |
| Operating activities | ||||
| Research & development | $15.05 | $12.19 | $13.52 | $10.33 |
| Selling, general & administrative | $127.81 | $123.07 | $102.15 | $102.42 |
| Total operating expenses | $142.18 | $135.26 | $115.67 | $112.75 |
| Operating income | $159.87 | $145.19 | $127.5 | $111.15 |
| Income from continuing operations | ||||
| EBIT | $159.87 | $144.02 | $127.69 | $110.86 |
| Income tax expense | $28.72 | $28.38 | $29.13 | $21.79 |
| Interest expense | $22.61 | $10.27 | $2.46 | $4.44 |
| Net income | ||||
| Net income | $108.54 | $105.37 | $96.1 | $84.62 |
| Income (for common shares) | $108.54 | $105.37 | $96.1 | $84.62 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $32.07 | $28.99 | $26.65 | |
| Operating activities | ||||
| Depreciation | $12.51 | $13.67 | $14.06 | |
| Business acquisitions & disposals | -$0.04 | -$0.04 | -$0.29 | |
| Stock-based compensation | $3.89 | $4.75 | $3.79 | |
| Total cash flows from operations | $44.99 | $33.39 | $67.41 | |
| Investing activities | ||||
| Capital expenditures | -$6.82 | -$6.7 | -$11.57 | |
| Investments | ||||
| Total cash flows from investing | -$22.78 | -$6.86 | -$6.74 | -$11.87 |
| Financing activities | ||||
| Dividends paid | -$25.57 | -$0.01 | -$25.55 | |
| Sale and purchase of stock | $0.88 | $3.59 | $0.91 | |
| Net borrowings | -$35.05 | -$8.06 | -$71.06 | |
| Total cash flows from financing | -$98.6 | -$34.19 | -$30.02 | -$70.15 |
| Effect of exchange rate | $0.94 | -$0.56 | -$0.72 | $2.1 |
| Change in cash and equivalents | $9.25 | $3.39 | -$4.1 | -$12.51 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $108.54 | $105.37 | $96.1 | $84.62 |
| Operating activities | ||||
| Depreciation | $54.94 | $51.85 | $48.88 | $51.28 |
| Business acquisitions & disposals | -$1.54 | -$365.78 | $0.32 | $0.09 |
| Stock-based compensation | $16.05 | $13.22 | $10.8 | $8.3 |
| Total cash flows from operations | $183.76 | $138.54 | $160.51 | $150.49 |
| Investing activities | ||||
| Capital expenditures | -$36.01 | -$50.08 | -$37.45 | -$33.83 |
| Investments | $2.74 | -$0.15 | -$0.85 | |
| Total cash flows from investing | -$34.81 | -$416.01 | -$35.3 | -$34.59 |
| Financing activities | ||||
| Dividends paid | -$22.87 | -$20.71 | -$18.72 | -$16.7 |
| Sale and purchase of stock | $0.77 | -$32.21 | -$28.3 | $0.69 |
| Net borrowings | -$131.22 | $300.83 | -$55.16 | -$85.15 |
| Total cash flows from financing | -$153.32 | $246.68 | -$102.18 | -$101.16 |
| Effect of exchange rate | $2.26 | -$5.88 | -$4.37 | $4.16 |
| Change in cash and equivalents | -$2.11 | -$36.68 | $18.67 | $18.9 |
News
Fundamentals
| Market cap | $4.99B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 32.51M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.52 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.98 |
| Quick ratio | 1.90 |